Prothena (NASDAQ:PRTA) Raised to “Hold” at StockNews.com
Prothena (NASDAQ:PRTA – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. PRTA has been the topic of several other research reports. Oppenheimer lifted their price objective on Prothena from $58.00 to $62.00 and gave the stock an […]
Prothena (NASDAQ:PRTA – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday. PRTA has been the topic of several other research reports. Oppenheimer lifted their price objective on Prothena from $58.00 to $62.00 and gave the stock an […]
